Enhabit, Inc. (EHAB) Price Target Analysis
Updated Jun 18, 2026
Analyst Rating: Hold
Based on 11 analysts2.0% Above Target
EHAB trades 2.0% above Wall Street's consensus target of $13.53.
Current Price$13.80
Average Target$13.53
Target
Current
Low$12.00
Median$13.80
High$14.00
Analyst Target Range
Forward P/E23.0x
(Fair)
PEG Ratio—
Implied Growth+1091.7%
(High Growth)
Analyst Spread14.8%
(High Agreement)
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Consensus Scenario Assumptions
The base valuation assumes EHAB achieves its forward estimates and maintains a stable P/E multiple of 23.0x. This scenario reflects the blended consensus of 11 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
EHAB Price Target Analysis
Updated June 22, 2026As of June 22, 2026, Enhabit, Inc. (EHAB) has a Wall Street consensus price target of $13.53, based on estimates from 11 covering analysts. With the stock currently trading at $13.80, this represents a potential downside of -2.0%. The company has a market capitalization of $707M.
Analyst price targets range from a low of $12.00 to a high of $14.00, representing a 15% spread in expectations. The median target of $13.80 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 2 analysts rating the stock as a Buy or Strong Buy,8 rating it Hold, and 1 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, EHAB trades at a trailing P/E of -152.3x and forward P/E of 23.0x. Analysts expect EPS to grow +1091.7% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside
+14.6%
Industry Consensus
Avg Forward P/E
21.3x
(Fair)
Peers with Coverage
10 / 10
Active Analyst Tracking
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 ADUSAddus HomeCare Corporation | $1.8B | $94.23 | $122.00 | +29.5% | Buy | 13.5x | 16 |
 ENSGThe Ensign Group, Inc. | $9.0B | $153.65 | $222.33 | +44.7% | Buy | 20.3x | 13 |
 SGRYSurgery Partners, Inc. | $1.9B | $14.55 | $19.33 | +32.9% | Buy | 33.9x | 22 |
 ACHCAcadia Healthcare Company, Inc. | $2.3B | $24.87 | $28.33 | +13.9% | Buy | 16.5x | 25 |
 SEMSelect Medical Holdings Corporation | $2.1B | $16.54 | $17.75 | +7.3% | Hold | 13.6x | 14 |
 PNTGThe Pennant Group, Inc. | $1.2B | $33.44 | $39.00 | +16.6% | Buy | 24.7x | 7 |
 UNHUnitedHealth Group Incorporated | $363.9B | $400.96 | $425.81 | +6.2% | Buy | 21.8x | 52 |
 HUMHumana Inc. | $43.3B | $360.65 | $298.50 | -17.2% | Hold | 40.8x | 44 |
 CVSCVS Health Corporation | $125.4B | $98.32 | $103.64 | +5.4% | Buy | 13.3x | 41 |
 ELVElevance Health Inc. | $84.4B | $388.50 | $415.19 | +6.9% | Buy | 14.5x | 37 |
EHAB — Frequently Asked Questions
Quick answers to the most common questions about buying EHAB stock.
What is the EHAB stock price target for 2026?
Wall Street's consensus price target for EHAB is $13.53, -2.0% from its current price of $13.8. The below-market target from 11 analysts suggests limited near-term appreciation.
Is EHAB a buy, sell, or hold?
EHAB has a consensus rating of "Hold" based on 11 Wall Street analysts. The rating breakdown is mixed, with 8 Hold ratings making up the largest segment. The consensus 12-month price target of $13.53 implies -2.0% downside from current levels.
Is EHAB stock overvalued or undervalued?
EHAB trades at a forward P/E of 23x, representing a moderate valuation. With analysts targeting $13.53 (-2.0% implied move), the stock appears close to fair value.
How high can EHAB stock go?
The most bullish Wall Street analyst has a price target of $14 for EHAB, while the most conservative target is $12. The consensus of $13.53 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover EHAB stock?
EHAB is moderately covered, with 11 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 8 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the EHAB stock forecast?
The 12-month EHAB stock forecast based on 11 Wall Street analysts shows a consensus price target of $13.53, with estimates ranging from $12 (bear case) to $14 (bull case). The median consensus rating is "Hold".
What is EHAB's forward P/E ratio?
EHAB trades at a forward P/E ratio of 23.0x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy EHAB stock?
Analysts are cautious on EHAB, with 1 Sell ratings and a price target of $13.53 (-2.0% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do EHAB price targets vary so much?
EHAB analyst price targets range from $12 to $14, a 15% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $13.53 consensus represents the middle ground.
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare